Inoue K, Osaka H, Kawanishi C, Sugiyama N, Ishii M, Sugita K, Yamada Y, Kosaka K
Department of Psychiatry, Yokohama City University, School of Medicine, Japan.
Neurology. 1997 Jan;48(1):283-5. doi: 10.1212/wnl.48.1.283.
Pelizaeus-Merzbacher disease (PMD) is a rare X-linked dysmyelinating disorder of the CNS resulting from abnormalities in the proteolipid protein (PLP) gene. Exonic mutations in the PLP gene are present in 10 to 25% of all cases. In investigating genotype-phenotype correlations, we screened five Japanese families with PMD for PLP gene mutations and compared their clinical manifestations. We identified two novel nucleotide substitutions in exon 5, at V208N and at P210L, in two families. In the remaining three families, there were no mutations detected. Although all patients satisfied the criteria for the classical form of PMD, two families not carrying the mutations showed milder clinical manifestations than those with the mutations. Since linkage analysis has shown homogeneity at the PLP locus in patients with PMD, our findings suggest that there may be genetic abnormalities other than exonic mutations that cause milder forms of PMD.
佩利措伊斯-梅茨巴赫病(PMD)是一种罕见的中枢神经系统X连锁脱髓鞘疾病,由蛋白脂蛋白(PLP)基因异常引起。PLP基因的外显子突变存在于所有病例的10%至25%中。在研究基因型与表型的相关性时,我们对五个患有PMD的日本家庭进行了PLP基因突变筛查,并比较了他们的临床表现。我们在两个家庭的外显子5中发现了两个新的核苷酸替换,分别是V208N和P210L。在其余三个家庭中,未检测到突变。尽管所有患者都符合经典型PMD的标准,但两个未携带突变的家庭临床表现比携带突变的家庭更轻。由于连锁分析表明PMD患者的PLP基因座具有同质性,我们的研究结果表明,除了外显子突变外,可能还存在导致较轻形式PMD的基因异常。